Investing.com - Assembly Biosciences reported on Tuesday third quarter earnings that missed analysts' forecasts and revenue that was inline with expectations.
Assembly Biosciences announced earnings per share of $-0.480 on revenue of $0.00. Analysts polled by Investing.com EPS of $-0.367 on revenue of $0.00.
Assembly Biosciences 's are down 16% and is trading at $1.370 , still down 56.51% from its 52 week high of $3.15 set on Tuesday, November 9, 2021.
Assembly Biosciences follows other major Healthcare sector earnings this month
Assembly Biosciences's report follows an earnings beat by UnitedHealth on Friday, October 14, 2022, who reported EPS of $5.79 on revenue of $80.89B, EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on Tuesday, October 18, 2022 with third quarter EPS of $2.55 on revenue of $23.79B, for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar